European position statement on lung cancer screening.

[1]  S. Lam,et al.  Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. , 2017, The Lancet. Oncology.

[2]  Harry J de Koning,et al.  Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening , 2017, Thorax.

[3]  S. Lam,et al.  The Cost‐Effectiveness of High‐Risk Lung Cancer Screening and Drivers of Program Efficiency , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  D. Manners,et al.  Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool , 2017, International journal of cancer.

[5]  S. Duffy,et al.  Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial , 2017, Thorax.

[6]  S. Duffy,et al.  Abstract 4220: Liverpool healthy lung project: a primary care initiative to identify hard to reach individuals with a high risk of developing lung cancer , 2017 .

[7]  C. la Vecchia,et al.  Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials , 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[8]  H. D. de Koning,et al.  Quantification of growth patterns of screen-detected lung cancers: The NELSON study. , 2017, Lung cancer.

[9]  Eugenio Paci,et al.  Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial , 2017, Thorax.

[10]  Harry J de Koning,et al.  Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study , 2017, PLoS medicine.

[11]  C. Henschke,et al.  Size and Growth Assessment of Pulmonary Nodules: Consequences of the Rounding , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  H. D. de Koning,et al.  Risk stratification based on screening history: the NELSON lung cancer screening study , 2017, Thorax.

[13]  P. K. Gerke,et al.  Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules? , 2017, Radiology.

[14]  Bram van Ginneken,et al.  Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines , 2017, European Radiology.

[15]  P. V. Van Schil,et al.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  M. Jantz,et al.  The American College of Radiology Lung Imaging Reporting and Data System: Potential Drawbacks and Need for Revision , 2017, Chest.

[17]  A. Edwards,et al.  The role of screening expectations in modifying short-term psychological responses to low-dose computed tomography lung cancer screening among high-risk individuals. , 2017, Patient education and counseling.

[18]  D. Origgi,et al.  Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis , 2017, British Medical Journal.

[19]  H. D. de Koning,et al.  Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada , 2017, PLoS medicine.

[20]  Layla Haidrani.  Pulmonary Nodule Risk. , 2017, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[21]  Bram van Ginneken,et al.  Towards automatic pulmonary nodule management in lung cancer screening with deep learning , 2016, Scientific Reports.

[22]  M. Oudkerk,et al.  P1.03-042 Nodule Size is Poorly Represented by Nodule Diameter in Low-Dose CT Lung Cancer Screening: Topic: Screening , 2017 .

[23]  H. Kauczor,et al.  Screening for lung cancer: Does MRI have a role? , 2017, European journal of radiology.

[24]  D. Collingridge.  17th World Conference on Lung Cancer. , 2017, The Lancet. Oncology.

[25]  Dennis J. Hazelett,et al.  The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[26]  S. Duffy,et al.  Implementation planning for lung cancer screening: five major challenges. , 2016, The Lancet. Respiratory medicine.

[27]  C. Henschke,et al.  Lung cancer: Low-dose CT screening — determining the right interval , 2016, Nature Reviews Clinical Oncology.

[28]  P. V. van Ooijen,et al.  Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. , 2016, The Lancet. Oncology.

[29]  P. V. van Ooijen,et al.  Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval , 2016, Thorax.

[30]  Stephanie A Kovalchik,et al.  Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. , 2016, JAMA.

[31]  John K Field,et al.  The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. , 2016, Health technology assessment.

[32]  B. Kramer,et al.  Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. , 2016, The Lancet. Oncology.

[33]  J. Zulueta,et al.  Lung cancer screening in patients with chronic obstructive pulmonary disease. , 2016, Annals of translational medicine.

[34]  Asger Dirksen,et al.  Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling. , 2016, American journal of respiratory and critical care medicine.

[35]  Cynthia Fraser,et al.  Alpha-2 agonists for sedation of mechanically ventilated adults in intensive care units: a systematic review. , 2016, Health technology assessment.

[36]  Nicola Sverzellati,et al.  Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen , 2016, European Radiology.

[37]  Sebastian Flacke,et al.  Performance of ACR Lung-RADS in a Clinical CT Lung Screening Program. , 2016, Journal of the American College of Radiology : JACR.

[38]  M. Kalra,et al.  The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

[39]  C. la Vecchia,et al.  Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening , 2015, Oncotarget.

[40]  G. Silvestri,et al.  A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer. , 2015, The New England journal of medicine.

[41]  M. Prokop,et al.  British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE , 2015, Thorax.

[42]  H. Boeing,et al.  Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort , 2015, Cancer Prevention Research.

[43]  H. Kauczor,et al.  Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[44]  M. Scorsetti,et al.  Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. , 2015, American journal of respiratory and critical care medicine.

[45]  E. Kazerooni,et al.  Performance of Lung-RADS in the National Lung Screening Trial , 2015, Annals of Internal Medicine.

[46]  Harry J de Koning,et al.  Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. , 2014, The Lancet. Oncology.

[47]  David F Yankelevitz,et al.  Retrospective review of lung cancers diagnosed in annual rounds of CT screening. , 2014, AJR. American journal of roentgenology.

[48]  John K. Field,et al.  Perspective: The screening imperative , 2014, Nature.

[49]  C. Berg,et al.  Impact of lung cancer screening results on smoking cessation. , 2014, Journal of the National Cancer Institute.

[50]  S. Duffy,et al.  Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom , 2014, British Journal of Cancer.

[51]  B. Ginneken,et al.  Interscan variation of semi-automated volumetry of subsolid pulmonary nodules , 2014, European Radiology.

[52]  J. Jett,et al.  Screening for lung cancer: The US studies , 2013, Journal of surgical oncology.

[53]  H. D. de Koning,et al.  European randomized lung cancer screening trials: Post NLST , 2013, Journal of surgical oncology.

[54]  D. de Ruysscher,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[55]  S. Lam,et al.  Probability of cancer in pulmonary nodules detected on first screening CT. , 2013, The New England journal of medicine.

[56]  Matthijs Oudkerk,et al.  Prospects for population screening and diagnosis of lung cancer , 2013, The Lancet.

[57]  C. Berg,et al.  Targeting of low-dose CT screening according to the risk of lung-cancer death. , 2013, The New England journal of medicine.

[58]  H. D. de Koning,et al.  Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial , 2013, European Respiratory Journal.

[59]  Timothy R Church,et al.  Selection criteria for lung-cancer screening. , 2013, The New England journal of medicine.

[60]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[61]  Ulrike Tisch,et al.  A nanomaterial-based breath test for short-term follow-up after lung tumor resection. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[62]  S. Duffy,et al.  Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer , 2012, Annals of Internal Medicine.

[63]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[64]  Ali O. Farooqi,et al.  Lung cancers diagnosed at annual CT screening: volume doubling times. , 2012, Radiology.

[65]  Ugo Pastorino,et al.  Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[66]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[67]  H. D. de Koning,et al.  Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON) , 2009, British Journal of Cancer.

[68]  Harry J de Koning,et al.  Management of lung nodules detected by volume CT scanning. , 2009, The New England journal of medicine.

[69]  B. Ginneken,et al.  A comparison of six software packages for evaluation of solid lung nodules using semi-automated volumetry: What is the minimum increase in size to detect growth in repeated CT examinations , 2009, European Radiology.

[70]  A. Dirksen,et al.  Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST) , 2008, Thorax.

[71]  David O Wilson,et al.  The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. , 2008, American journal of respiratory and critical care medicine.

[72]  J. Mulshine,et al.  Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. , 2008, Lung cancer.

[73]  Harry J de Koning,et al.  Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial) , 2008, Cancer.

[74]  Paolo Vineis,et al.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.

[75]  S. Duffy,et al.  The LLP risk model: an individual risk prediction model for lung cancer , 2007, British Journal of Cancer.

[76]  R Holland,et al.  European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. , 2008, Annals of Oncology.

[77]  Matthew B Schabath,et al.  A risk model for prediction of lung cancer. , 2007, Journal of the National Cancer Institute.

[78]  C. Henschke,et al.  Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. , 2007, Lung cancer.

[79]  O. Miettinen,et al.  Survival of Patients with Stage I Lung Cancer Detected on CT Screening , 2008 .

[80]  O. Hoekstra,et al.  Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. , 2005, Chest.

[81]  C. Begg,et al.  Variations in lung cancer risk among smokers. , 2003, Journal of the National Cancer Institute.

[82]  S. Swensen,et al.  Screening for lung cancer with low-dose spiral computed tomography. , 2000, American journal of respiratory and critical care medicine.

[83]  O S Miettinen,et al.  Early Lung Cancer Action Project , 2001, Cancer.

[84]  P C Prorok,et al.  Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. , 2000, Journal of the National Cancer Institute.

[85]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[86]  W F Taylor,et al.  Lung cancer screening: the Mayo program. , 1986, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[87]  Bernard Maitre,et al.  Screening by Chest Radiograph and Lung Cancer Mortality : The Prostate , Lung , Colorectal , and Ovarian ( PLCO ) Randomized Trial , 2022 .